According to a clinical research plan updated by the company in early 2024, Lilly will conduct multiple Phase 3 clinical trials for Retatrutide over the next three years, with targeted indications primarily including obesity, chronic kidney disease, and type 2 diabetes
There is another drug with the same use and effects as semaglutide, tirzepatide
Patients transitioning from any other compounded GLP-1 platform should document their current medication, current weekly dose, duration at that dose, and clinical response in the Direct Meds intake questionnaire
Meanwhile, Zepbound is the same drug formulation for the treatment of both obesity and/or obstructive sleep apnea
Tirzepatide Discover the top 10 peptides for weight loss & recovery in 2026 that are trending in the health community today